Bismuth-guided cavity confinement breaks the stability-utilization trade-off in zinc powder anodes
Abstract
The practical application of aqueous zinc-ion batteries (AZIBs) is severely hindered by the poor reversibility of the Zn anode, which stems from a self-amplifying cycle involving dendrite growth, interfacial side reactions, and electrically isolated "dead Zn" formation. Here, we report a spray-assembled three-dimensional copper mesh-supported particulate Zn anode, in which Zn particles are encapsulated by an inner bismuth interlayer and an outer carbon confinement shell (3D-C/Bi@Zn-p). Unlike conventional surface stabilization strategies, this surface-engineered architecture enables a unique interface-guided, cavity-confined inward deposition mechanism. During stripping, Zn is selectively extracted from the particle core, leaving behind a robust bismuth-carbon composite shell embedded with isolated internal cavities. In the subsequent plating step, the passivated carbon outer layer effectively suppresses parasitic reactions and prevents Zn nucleation on the external surface, while the inner bismuth layer provides a highly zincophilic interface that kinetically directs Zn2+ to undergo plating exclusively in the cavity interior. Consequently, Zn plating is spatially confined within isolated cavities, effectively suppressing outward dendrite propagation and eliminating the risk of short circuits. Benefiting from this cavity-confined inward deposition behavior, the 3D-C/Bi@Zn-p anode delivers a coulombic efficiency approaching 100% and enables record-high stable cycling for over…
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.